Wang, Maxime M.
Flores, Roberto L.
Witek, Lukasz
Torroni, Andrea
Ibrahim, Amel
Wang, Zhong
Liss, Hannah A.
Cronstein, Bruce N.
Lopez, Christopher D.
Maliha, Samantha G.
Coelho, Paulo G.
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (HD090664-01)
Article History
Received: 30 July 2019
Accepted: 12 November 2019
First Online: 5 December 2019
Competing interests
: B.C. has patented the use of dipyridamole-loaded 3D printed biodegradable scaffolds for the treatment of critical bone defects. P.C. has patented the 3D printing device configuration for bone regeneration. B.C. and P.C. were funded by the National Institutes of Health [Grand #: R21/R33 HD090664-01 “Use of 3D Printing for Creation of Implantable Pediatric Devices”] B.C. and P.C. were further supported by grants NIH [R01 AR068593] and NYU-H+H Clinical and Translational Science Institute Grant (1UL1TR001445). M.W., R.F., L.W., A.T., A.I., Z.W., H.L., C.L. and S.M. declare no potential conflict of interest.